1. Home
  2. FSP vs LONA Comparison

FSP vs LONA Comparison

Compare FSP & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.38

Market Cap

33.3M

Sector

Real Estate

ML Signal

HOLD

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

HOLD

Current Price

$2.04

Market Cap

32.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
LONA
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
32.7M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
FSP
LONA
Price
$0.38
$2.04
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $16.00
AVG Volume (30 Days)
★ 591.3K
57.8K
Earning Date
10-27-2026
11-16-2026
Dividend Yield
★ 2.66%
N/A
EPS Growth
★ 15.69
N/A
EPS
★ N/A
N/A
Revenue
★ $107,162,000.00
N/A
Revenue This Year
$16.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.30
$2.21
52 Week High
$1.05
$14.21

Technical Indicators

Market Signals
Indicator
FSP
LONA
Relative Strength Index (RSI) 44.11 17.72
Support Level $0.31 N/A
Resistance Level $0.40 $9.92
Average True Range (ATR) 0.03 0.48
MACD -0.01 -0.19
Stochastic Oscillator 9.57 4.35

Price Performance

Historical Comparison
FSP
LONA

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: